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Abstract: Psoriasis is a long-term skin disorder without a cure, whose patients are particularly
susceptible to mental health diseases. Using a sample of patients diagnosed with psoriasis, this study
aimed to: (1) identify the clinical and positive psychological variables that contribute the most to
psoriasis disability and (2) assess the mediator role of body image-related cognitive fusion in the
relation between disease severity perception and acceptance and self-compassion, on one hand,
and psoriasis disability on the other. This is an initial cross-sectional exploratory study, with 75 patients
diagnosed with psoriasis (males 52%; mean age 54.99 ± 13.72) answering a sociodemographic and a
clinical questionnaire, the Psoriasis Disability Index (PDI), the Cognitive Fusion Questionnaire—Body
Image (CFQ-BI), the Acceptance and Action Questionnaire—II (AAQ-II), and the Self-Compassion
Scale (SCS). Descriptive and inferential statistics were used to characterize and assess the measures and
the final model used. Through path analysis and a hierarchical multiple linear regression, it was found
that the variables that significantly contributed to psoriasis disability were years of education, impact
on social life and body image, explaining 70% of the variance. Body image-related cognitive fusion
was a significant mediator in the relationship between disease severity and acceptance, and psoriasis
disability. The implications of this study are considered to be extremely relevant, since it will allow
additional information to be provided to psoriasis patients, appropriated to their educational level,
aiming to reduce distorted perceptions of disease severity and intervene in the ability to accept this
specific and important chronic health condition.
Keywords: acceptance; body image-related cognitive fusion; disease severity perception; psoriasis
disability; self-compassion
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1. Introduction
Psoriasis is a long-term skin disorder that has no cure [1] and may express itself as an active severe
disease or as mild stable disease [2]. Psoriasis patients are more susceptible to mental health diseases
than patients with other dermatological conditions [3]. It is recognized that the risk of depression,
anxiety, and suicidality is higher in patients with psoriasis [4]. The impact of psoriasis on patients’ lives
can be assessed by different instruments, namely, the Psoriasis Disability Index (PDI) [5]. However,
the variables that contribute to the impact of this specific disease on mental health are not fully known.
Several psychological constructs have been studied in clinical samples of patients with psoriasis,
e.g., depression [6], anxiety [7], embitterment [8], stigmatization [9], isolation [10], quality of life [11]
and body image [12,13]. All these studies report worse outcomes for patients with psoriasis than for
controls, i.e., more depression, more anxiety, more embitterment, more stigmatization, more isolation,
less quality of life and worse body image.
Other studies have focused on positive constructs, such as acceptance [14] and self-compassion [15].
These studies assume that acceptance and self-compassion improve the perception of the disease,
thus contributing to a better quality of life; acceptance is recognized as the ability to experience
undesired private events, in order to pursue one’s values and goals [16]. On the contrary, experiential
avoidance is the effort to change the form, frequency, or situational sensitivity of sensible private
events, namely, thoughts, feelings and physiological sensations, even if this leads to inconsistent
actions involving values and goals [16,17]. Acceptance and experiential avoidance are examples of
psychological flexibility and inflexibility, respectively. Psychological flexibility is the “ability to fully
contact the present moment and the thoughts and feelings it contains without needless defense” [18]
(p. 7). Psychological inflexibility includes rigid dominance of psychological reactions in guiding
actions. This happens when people fuse with evaluative and self-descriptive thoughts and try to
avoid experiencing undesired internal events, decreasing their contact with the present moment [17].
Self-compassion is a complex construct including three essential elements: treating oneself with
kindness, recognizing one’s imperfections as part of the common human experience, and maintaining
a balanced awareness of one’s thoughts and feelings [19].
In a state of cognitive fusion, persons behave according to their thoughts, considering them real,
truthful and wise; cognitive fusion is the degree to which an individual interacts with events regarding
their verbal functions rather than their direct ones [20]. This leads to self-identification with one’s
thoughts and inabilities, considering them as part of an inner experience [21]. Body image is a concept
that includes the subjective perceptions of the individual formed by their feelings and beliefs related
to his/her own body [22]. Body image-related cognitive fusion is linked to unfavorable social rank
perceptions [23]. Trindade and Ferreira [23] found that women “who get fused and tangled with
thoughts relating to body image have greater tendencies of developing disordered mechanisms in order
to “correct” their body dissatisfaction and social disadvantage” (p. 72). Body image dissatisfaction
can be due to the perception of a significant discrepancy between one’s real body image and one’s
desired one [24]. Since psoriasis manifests itself with the appearance of physical lesions, a negative
change in the patient’s body image may lead to a negative psychosocial impact, resulting in an increase
in body coverage as well as inhibition and reduction of physical exposure [25]. Depending on the
visibility, appearance and location, psoriasis physical lesions may be stigmatizing for patients, leading
to low self-esteem and negative perception of their body image [26]. Łakuta and Przybyła-Basista [27]
found that attitude towards the body mediates the relationship between the severity of psoriasis and
depression, and Lawrence, Fauerbach and Thombs [28] found that the importance of appearance
moderates the relationship between the subjective burn scars severity and body-esteem.
However, the mediator role of body image-related cognitive fusion between positive psychological
constructs and psoriasis disability has not yet been studied. To fill this gap, this study aims to (1) identify
the clinical and positive psychological variables that contribute the most to quality of life (psoriasis
disability) and (2) assess the mediator role of body image-related cognitive fusion in the relationship
Behav. Sci. 2020, 10, 142 3 of 13
between disease severity perception, acceptance and self-compassion, on one hand, and psoriasis
disability on the other, in a sample of patients diagnosed with psoriasis.
2. Materials and Methods
2.1. Participants and Procedures
The sample selection of 75 patients diagnosed with psoriasis (mean age 54.99 ± 13.72) intended to
be representative of the Portuguese population, comprising participants from all regions of the country
and with different professions. In line with this, participants were recruited by the Portuguese Psoriasis
Association (PSO Portugal). According to the PSO Portugal, psoriasis affects 1 to 3% of the Portuguese
population [29]. In this initial exploratory study, the inclusion criteria were to be 18 years old, educated
(i.e., at least 4 years of education) and with a diagnosis of psoriasis. All procedures performed in
studies involving human participants were in accordance with the ethical standards of the institutional
research committee under whose responsibility the study was carried out (31/CE-IUCS/2019) and with
the 1964 Helsinki declaration and its later amendments. In order to guarantee the ethical aspects
involved, the objectives of the study and the voluntary and confidential nature of the participation
were explained to participants. Informed consent, its acceptance and fulfillment were mandatory.
2.2. Measures
2.2.1. Sociodemographic and Clinical Questionnaire
The sociodemographic questionnaire included questions related to age, gender, marital status,
education and occupation, and the clinical questionnaire contained questions related to year of diagnosis
of psoriasis, family history of psoriasis, existence of other diseases, satisfaction with current psoriasis
treatment, disease severity perception, taking anxiolytics and antidepressants, and impact of psoriasis
disease on social life.
2.2.2. Psoriasis Disability Index
The Psoriasis Disability Index (PDI) [5] assesses the impact of psoriasis on patients’ lives. It consists
of 15 items divided in 5 subscales: daily activities, work/school or alternative questions, personal
relationships, leisure activities and treatment. The score of each question is given in 4 possible answers:
nothing (0), slightly (1), quite (2) and very (3), with a minimum of 0 points and a maximum of 45 points.
A higher value corresponds to a higher score of disability. The Portuguese version was validated by
Fernandes et al. [30], with a good level of internal consistency (α = 0.89).
2.2.3. Cognitive Fusion Questionnaire—Body Image
The Cognitive Fusion Questionnaire—Body Image (CFQ-BI) [31] assesses the extent to which
individuals “merge” with their own body image. It consists of 10 items on a Likert scale of 7 points,
where 1 corresponds to “never true” and 7 to “always true” for a total of 70 points. The Portuguese
version was translated and validated by Ferreira et al. [24], with a very good internal consistency
(α = 0.96), as well as convergent, divergent and temporal.
2.2.4. Acceptance and Action Questionnaire—II
Acceptance and Action Questionnaire—II (AAQ-II) [18] assesses psychological flexibility and
experiential avoidance. It consists of a scale of 10 Likert-type items ranging from 1 “never true”
to 7 “always true” for a total of 49 points. The quotation is obtained through the sum of scores,
with higher scores indicating greater psychological inflexibility or avoidance. The Portuguese version
was translated and adapted by Pinto-Gouveia and colleagues [32], with a very good level of internal
consistency (α = 0.90).
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2.2.5. Self-Compassion Scale
The Self-Compassion Scale (SCS) [33] assesses the self-compassion through 26 items and aims
to measure the three basic components of self-compassion: self-kindness, common humanity and
mindfulness. It is divided into 6 subscales: self-kindness, self-judgment, common humanity, isolation,
mindfulness and over-identification. The items are quoted on a 5-point Likert scale, where 1 corresponds
to “almost never” and 5 to “almost always” for a total of 130 points. The quotation is made by summing
the score of all items. Higher scores mean more self-compassion. The Portuguese version has been
translated and validated by Castilho and colleagues [34], with very good internal consistency (α = 0.92).
2.3. Data Analysis
The sample was calculated a priori with version 4.0 of the Free Statistics Calculators, respecting
the criteria required for different types of studies, with a medium effect size (d = 0.50) and an alpha
of 0.05, specifying the minimum sample size needed to detect the adjusted effect according to the
structural complexity of the model (n = 63). However, 75 participants were recruited through PSO
Portugal and thus included in the study. Descriptive statistics were used to characterize the sample
from a sociodemographic and clinical point of view, as well as the psychological variables. Through a
Student’s t-test, the differences between the values of psychological variables obtained in the study
and those obtained in studies conducted with the original versions of the instruments used in this
study, were calculated. Chronbach’s alpha was used to assess the reliability of the measures. A Pearson
correlation was performed to analyze the associations between demographic, clinical and psychological
variables with the outcome (PDI). In order to examine the comparative strength of direct and indirect
effects among variables, a path analysis was chosen. The robust maximum likelihood estimation
procedure was used to account for the non-normality of the data. The adequacy of the model was
assessed according to the goodness-of-fit indexes. The Satorra-Bentler Scale chi-square test was used.
Non-significance of p value (p > 0.05) and the ratio (S-Bχ2)/df < 3 represent a good model fit. Since the
significance of a chi-square test is dependent on the number of participants, other goodness-of-fit
indexes were used, namely, the Comparative Fit Index (CFI), with a maximum value of 1.00, for which
results above 0.90 suggest a good fit; and the Root Mean Square Error Approximation (RMSEA),
for which values below 0.05 indicate a good fit, and values up to 0.08 are acceptable. Additionally,
a hierarchical multiple linear regression was performed to assess the variables that significantly
contributed to psoriasis disability. In this study, there were no missing data. All analyses were
conducted with IBM SPSS and AMOS version 25, and a 0.05 level of significance was considered.
3. Results
3.1. Sample Characterization
The total sample (n = 75) used in this exploratory study is mostly male, with a mean age of
54.99 years, married or committed, not graduated and active (working). The sample reports having
a clinical diagnosis of psoriasis, on average, for 23.96 years. Most of the sample is satisfied with
the current treatment, has no other diseases, and does not take anxiolytics and antidepressants.
Additionally, the disease does not have a great impact in their social life, and the family has not history
of psoriasis. Detailed sociodemographic and clinical data is presented in Table 1.
3.2. Comparison Between Psoriasis Disability Index, Body Image-Related Cognitive Fusion, Acceptance and
Action, and Self-Compassion Frequencies in this Study and in the Original Authors’ Studies
There are statistically significant differences in most of the comparisons made between the values
presented in this study and the values presented by the original authors’ instruments [24,30,32,34]
with clinical samples in their studies. The sample of this study shows higher values in all dimensions
of the PDI, including the total, except in the work or school dimension (Table 2). The same can be stated
for the self-compassion scale, except for the self-judgment, isolation and over-identification dimensions.
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With respect to body image-related cognitive fusion and acceptance, the sample of this study presents
lower values, although very close to the last one.
Table 1. Sociodemographic and clinical characterization of the sample (n = 75).
Sociodemographic Variables %
Age (M ± SD) 54.99 ± 13.72
Gender (%)
Female 48.0
Male 52.0
Marital Status (%)
Not married/Committed 24.0
Married/Committed 76.0
Education (%)
Non-graduate 53.3
Graduate 46.7
Occupation (%)
Active 57.3
Inactive 42.7
Clinical variables
Years of diagnosis (M ± SD) 23.96 ± 15.40
Family history of psoriasis (%)
No 57.3
Yes 42.7
Other diseases (%)
No 56.0
Yes 44.0
Satisfaction with current treatment
(%)
No 30.7
Yes 69.3
Disease severity perception (%)
Mild 22.7
Moderate 58.7
Severe 18.7
Anxiolytics and antidepressants (%)
No 73.3
Yes 26.7
Impact in social life (%)
None or little 68.0
Some or a lot 32.0
M = mean; SD = Standard deviation; % = percentage; In bold the higher percentages.
Table 2. The Psoriasis Disability Index, Body Image-Related Cognitive Fusion, Acceptance and Action
and Self-Compassion Frequencies (n = 75) and a comparison of original authors’ instruments with
clinical samples.
Variables
This Study
Original Authors’
Instruments
Studies [24,30,32,34]
Statistical Comparison
n M SD α n M SD α t df p d
Psoriasis Disability Index (total) 75 8.44 7.33 0.82 171 2.10 1.60 0.89 7.414 77, 111 <0.001 1.95
Daily activities 75 4.44 3.95 0.87 171 3.10 2.20 0.83 2.756 94, 743 0.007 0.42
Work or school 75 0.93 1.48 0.56 171 0.99 1.70 0.75 −0.279 160, 962 0.780 0.04
Personal relationships 75 0.71 1.10 0.80 171 1.40 2.20 0.87 −3.273 239, 942 0.001 0.40
Leisure 75 1.67 1.88 0.57 171 1.70 2.10 0.85 −0.111 156, 724 0.912 0.02
Treatment (1 item) 75 0.69 0.77 − 171 2.30 2.90 − −6.738 216, 210 <0.001 0.76
Body Image Cognitive Fusion (total) 75 28.15 13.89 0.98 31 51.74 12.12 0.96 8.725 63, 792 <0.001 1.81
Acceptance and Action (total) 75 33.19 8.21 0.73 297 33.47 9.46 0.90 0.256 128, 332 0.799 0.03
Self-Compassion (total) 75 84.51 15.83 0.83 298 60.25 15.79 0.92 −12.643 89, 803 <0.001 1.53
Self-Kindness 75 13.77 4.35 0.83 298 10.57 3.87 0.92 −6.234 83, 743 <0.001 0.78
Self-Judgment 75 17.29 4.31 0.86 298 18.41 4.05 0.93 2.174 84, 904 0.032 0.27
Common Humanity 75 12.19 3.45 0.80 298 10.09 3.15 0.85 −5.102 84, 277 <0.001 0.64
Isolation 75 14.17 3.33 0.84 298 14.77 3.31 0.89 1.502 86, 246 0.137 0.18
Mindfulness 75 12.85 3.19 0.73 298 9.55 2.88 0.85 −8.678 84, 041 <0.001 1.09
Over-identification 75 14.23 3.19 0.79 298 14.77 3.24 0.88 1.408 86, 805 0.163 0.17
n = frequencies; M = mean; SD = standard deviation; α = Cronbach’s alpha; t = Student’s t-test; df = degrees of
freedom; p = p value; d = Cohen’s d effect size; bold = statistically significant differences.
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3.3. Correlations between Sociodemographic, Clinical and Psychological Variables
From Table 3, only the significant correlations stand out (the bold values indicated in
Table 3). Significant correlations are presented between sociodemographic and clinical variables
with psychological variables. Finally, the correlations between psychological variables stand out.
Years of education correlates negatively with treatment adherence (PDI). The existence of other diseases
in addition to psoriasis correlates positively with acceptance and negatively with self-compassion,
self-kindness, self-judgment and isolation. Family history of psoriasis correlates positively with
common humanity. Disease severity perception correlates positively with PDI (total), leisure and
body image-related cognitive fusion and negatively with self-kindness. Satisfaction with treatment
correlates negatively with work or school (PDI). Taking anxiolytics and or antidepressants correlates
positively with personal relationships, leisure and acceptance and negatively with self-compassion,
self-judgment, isolation and over-identification. Impact in social life correlates positively with
PDI (total), daily activities, work or school, personal relationships, leisure, body image-related
cognitive fusion and acceptance and negatively with self-compassion, self-judgment, isolation and
over-identification. Self-compassion correlates negatively with PDI (total) and all its dimensions, except
treatment, body image-related cognitive fusion and acceptance. Acceptance correlates positively with
PDI (total) and all its dimensions, except treatment. Body image-related cognitive fusion correlates
positively with PDI (total) and all its dimensions, except treatment, as shown in the correlations
between variables presented in Table 3.
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Table 3. Correlations between sociodemographic, clinical and psychological variables.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
1. Years of education 1 −0.028 0.053 −0.004 0.070 0.106 −0.031 −0.168 −0.187 −0.085 −0.044 −0.070 −0.236* −0.067 0.111 −0.079 0.067 −0.205 0.012 −0.055 −0.089 −0.076
2. Other diseases 1 0.159 0.097 0.182 0.194 0.098 0.087 0.120 −0.088 0.066 0.115 0.004 0.181 0.260*
−0.292
*
−0.239
*
−.230
* −0.189
−0.330
** −0.120 −0.140
3. Family history of psoriasis 1 0.054 0.106 0.089 −0.022 0.096 0.137 −0.016 −0.015 0.110 −0.007 0.116 0.106 0.042 0.132 −0.072 0.268* −0.086 0.083 −0.155
4. Disease severity perception 1 0.004 0.273*
0.460
**
0.247
* 0.213 0.195 0.173
0.311
** −0.134
0.269
* 0.218 −0.215
−0.229
* −0.185 −0.081 −0.122 −0.101 −0.186
5. Satisfaction with treatment 1 0.009 −0.051 −0.047 −0.036 −0.246* −0.020 0.021 0.187 −0.148 −0.031 −0.017 0.085 −0.029 0.045 −0.096 −0.040 −0.071
6. Anxiolytics/antidepressants 1 0.221 0.200 0.163 0.048 0.272*
0.252
* −0.034 0.219
0.252
*
−0.309
** −0.219
−.330
** 0.002
−.286
* −0.210
−0.281
*
7. Impact in social life 1 0.687**
0.671
**
0.462
**
0.494
**
0.564
** 0.114
0.645
**
0.432
**
−0.329
** −0.218
−0.432
** 0.026
−0.319
** −0.052
−0.394
**
8. PDI (total) 1 0.938**
0.656
**
0.677
**
0.822
**
0.455
**
0.764
**
0.521
**
−0.491
**
−0.353
**
−0.504
** −0.058
−0.440
**
−0.242
*
−0.510
**
9. Daily activities 1 0.492**
0.537
**
0.655
**
0.475
**
0.756
**
0.481
**
−0.447
**
−0.343
**
−0.437
** −0.065
−0.379
**
−0.238
*
−0.458
**
10. Work or school 1 0.344**
0.495
** 0.088
0.466
**
0.423
**
−0.364
** −0.218
−0.370
** −0.042
−0.356
** −0.191
−0.403
**
11. Personal relationships 1 0.591** 0.148
0.572
**
0.410
**
−0.439
**
−0.293
*
−0.495
** −0.078
−0.373
** −0.217
−0.420
**
12. Leisure 1 0.208 0.644** 0.408**
−0.411
**
−0.312
**
−0.436
** −0.071
−0.354
** −0.175
−0.406
**
13. Treatment 1 0.100 0.088 −0.039 0.003 −0.062 0.144 −0.158 0.025 −0.131
14. Body image (total) 1 0.540**
−0.615
**
−0.417
**
−0.570
** −0.194
−0.532
**
−0.341
**
−0.607
**
15. Acceptance Action (total) 1 −0.590**
−0.264
*
−0.540
** −0.172
−0.625
**
−0.347
**
−0.654
**
16. Self-compassion (total) 1 0.758**
0.732
**
0.570
**
0.770
**
0.752
**
0.771
**
17. Self-kindness 1 0.292*
0.657
**
0.261
*
0.737
**
0.282
*
18. Self-judgment 1 0.034 0.773** 0.214
0.825
**
19. Common Humanity 1 0.133 0.622** 0.043
20. Isolation 1 0.370**
0.864
**
21. Mindfulness 1 0.379**
22. Over-identification 1
* p < 0.05; ** p < 0.001; bold = statistically significant correlations
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3.4. Hierarchical Multiple Linear Regression: Predictors of Psoriasis Disability Index (Final Model)
In Table 4, model 1 includes sociodemographic variables. In addition to sociodemographic
variables, model 2 in Table 4 also includes clinical variables. Finally, model 3 presented in Table 4
includes sociodemographic, clinical and psychological variables. In relation to hierarchical multiple
linear regression, the variables that significantly contribute to PDI are years of education, impact on
social life and body image (model 3 in Table 4), explaining 70% of the variance [F (10, 65) = 14.794;
p < 0.001].
Table 4. Hierarchical Multiple Linear Regression: predictors of the Psoriasis Disability Index
(Final Model).
Model R R2 R
2
Adjusted
Standardized Error
of the Estimate
R2
Change
F
Change df1 df2
Significant
F Change
1 0.168 0.028 0.015 7.270 0.028 2.116 1 73 0.150
2 0.721 0.520 0.470 5.332 0.492 11.454 6 67 <0.001
3 0.835 0.698 0.651 4.328 0.178 12.558 3 64 <0.001
B Error β t p
1 (Constant) 13.012 3.253 −4.001 <0.001
Years of education −0.929 0.639 −0.168 −1.455 0.150
2 (Constant) −2.256 4.275 −0.528 0.599
Years of education −0.889 0.474 −0.160 −1.874 0.065
Other diseases −0.146 1.303 −0.010 −0.112 0.911
Family history of psoriasis 1.790 1.271 0.122 1.408 0.164
Disease severity perception −1.267 1.104 −0.112 −1.148 0.255
Satisfaction with treatment −0.175 1.369 −0.011 −0.128 0.899
Anxiolytics/antidepressants 1.307 1.491 0.079 0.877 0.384
Impact in social life 6.182 0.830 0.719 7.452 <0.001
3 (Constant) −0.613 7.159 −0.086 0.932
Years of education −0.897 0.393 −0.162 −2.282 0.026
Other diseases −1.590 1.102 −0.108 −1.443 0.154
Family history of psoriasis 0.958 1.089 0.065 0.880 0.382
Disease severity perception −0.963 0.903 −0.085 −1.067 0.290
Satisfaction with treatment 0.984 1.144 0.062 0.861 0.393
Anxiolytics/antidepressants 0.318 1.240 0.019 0.257 0.798
Impact in social life 3.160 0.886 0.367 3.567 0.001
Body image (total) 0.228 0.062 0.433 3.694 <0.001
Acceptance Action (total) 0.119 0.083 0.134 1.444 0.153
Self-compassion (total) −0.039 0.048 −0.083 −0.799 0.427
Notes: R = multiple correlation coefficient; R2 = explanation factor (how much of the variation is explained by
the model); R2 adjusted = percentage of variance that would not be explained by the model if it were derived
from the population instead of a sample; df 1 = numerator degrees of freedom; df 2 = denominator degrees of
freedom; β = slope gradient; F = analysis of variance ANOVA; t = informs whether the value of β is different from 0;
p = significance value; bold = statistically significant differences.
3.5. Body Image as Mediator of Acceptance and Disease Severity Perception, and PDI
The results of the path analysis with the standardized regression coefficients for PDI are presented
in Figure 1, and this model has a good fit. d1 and e2 are errors, i.e., the proportion of the variance that
is not explained by the variable.
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Figure 1. Path analysis of body image as mediator of acceptance and disease severity perception,
and Psoriasis Disability Index (PDI); fit indices: χ2 = 1.28, p < 0.001, CFI = 0.991, RMSEA = 0.053.
Body image-related cognitive fus on was found to have a significant mediator role in the
relationship between disease severity and acceptance on one hand, and the PDI on the other, being the
indirect effects significative (Table 5).
Tabl 5. Path analysis of body im ge as a mediator of acceptance and disease severity perception, and
the Psoriasis Disability Index; indirect effects.
Independent
Variable
Mediator
Variable
Dependent
Variable
B Mean
Indirect
Effect
SE of
Mean
95% CI Mean
Indirect Effect
(Lower and Upper)
p
Disease severity
perception Body image
Psoriasis
disability
index
0.035 0.004 0.028; 0.043 <0.001 ***
Acceptance and
action 0.444 0.041 0.368; 0.530 <0.001 ***
*** p < 0.001; B = the indirect effect represents the portion of the relationship between X (independent variable) and
Y (de endent variable) that is mediated by body image; SE = Standard error; CI = confidence interval.
4. Discussi
The aims of this study were to identify the variables that contribute most to the quality of
life of psoriasis patients (psoriasis disability) and to assess the mediator role of body image-related
cognitive fusion in the relationship between disease severity perception, acceptance, self-compassion
and psoriasis disability.
In relation to the representativeness of the sample, it was found that 1% of individuals with
Psoriasis in Portugal are represented, which is in accordance with the latest statistics available [29].
Alongside, and in agreement with the available data [29], men and women in this study have the
same chance to develop psoriasis and are more likely to be diagnosed between 20 and 30 years old.
Although psoriasis is usually associated with somatic comorbidities, with cardiovascular risk and
associated diseases being one of its aspects, the sample in this study mainly reports no other diseases
and does not take anxiolytics and antidepressants. This discrepancy can be explained by the fact that
most of the sample perceives the severity of psoriasis disease as moderate.
Self-compassion did not contribute to explaining psoriasis disability, although Stuntzner [35]
considers that compassion is a component of adjustment to disability. Regarding the first objective of the
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study, the clinical and positive psychological variables that contribute most to quality of life (psoriasis
disability), years of education, impact of psoriasis on social life and body image-related cognitive
fusion were identified as contributors in explaining psoriasis disability. In this study, the variable
years of education is negatively correlated with treatment (PDI), suggesting that patients with more
education deal with and manage the disease better than those with less education. According to
Groot and colleagues [36], maternal educational attainment and equivalized household income were
inversely associated with psoriasis in offspring. Löfvendahl and colleagues [37] found that fewer years
of education in patients with psoriasis was associated with increased use of primary health services.
However, Kimball and colleagues [38] found a positive association between poor psoriasis control and
lower education.
Although most of the sample reports that the disease has little impact on their social life, this impact
is one of the variables that significantly contributes to explaining the quality of life (psoriasis disability)
of the patients. In fact, physical expression of the disease causes embarrassment in the patients, leading
them to avoid social exposure and promoting isolation behaviors, which, in turn, impact the quality of
life associated with psoriasis [39]. Indeed, patients with psoriasis and their families have psychosocial
impairments [40]. Psoriasis diminishes the life potential of affected patients, a phenomenon called
“Cumulative Life Course Impairment” [41]: stigmatization, psychological morbidity and social isolation
may, over time, deeply impact education, profession, life course and income [42].
Additionally, body image-related cognitive fusion significantly explains PDI, correlating positively
with it. The visible appearance of the physical lesions negatively impacts body image-related cognitive
fusion, which leads to a decrease in patient’s quality of life [43]. Wojtyna et al. [44] found that improving
the body image of patients with psoriasis by reducing its salience in their personal lives may prevent
depression, above all, in women. However, Trindade and Ferreira [23] proposed the promotion of
cognitive fusion and acceptance of inner events to construct a healthy skepticism about one’s thoughts.
In relation to the second objective of the study, the mediator role of body image-related cognitive
fusion between disease severity perception and acceptance and quality of life (psoriasis disability)
was confirmed. This result is in line with Łakuta and Przybyła-Basista’s [45] study, which found
that emotional attitude towards the body mediates the relationship between self-reported severity
of psoriasis and depression. It is also in line with Lawrence and colleagues’ [28] study, which found
that the importance of appearance moderated the relationship between subjective burn scars severity
and body-esteem.
Although psychosocial comorbidities are not always proportional to psoriasis severity and
perception of psoriasis severity is not always proportional to psoriasis severity [45], patients with
psoriasis report more subjective health complains than controls [46]. The location and size of the
physical lesions is the second most important factor that contributes to explaining psoriasis disease
severity perception [47], suggesting a relationship between disease severity perception and body image
that is negatively affected in patients with psoriasis [44]. In addition, body image-related cognitive
fusion is positively associated with anxiety and depression [31,48].
Acceptance of the disease is a strong determinant of quality of life in psoriasis patients [49]. It is
associated with body image-related cognitive fusion, which has a buffering effect on the consequences
of psoriasis [49]. Perceiving the disease as an obstacle and being aware that the health locus of control is
internal determines the degree of acceptance of psoriasis [14]. Acceptance of the disease and satisfaction
with the body and its positive image are associated with feelings of personal happiness [13]. In fact,
Acceptance and Commitment Therapy (ACT) seeks to counteract cognitive fusion and experiential
avoidance, which are two processes of psychological inflexibility [50]. Also, the aggregated effect of
experiential avoidance and cognitive fusion is relevant to perceived burdensomeness in the extreme
form of experiential avoidance, i.e., suicide [51].
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5. Conclusions
Psoriasis is a specific and important chronic health condition, a long-term skin disorder with no
cure, and diagnosed patients are particularly susceptible to experience worse quality of life.
Using path analysis and hierarchical multiple linear regression, the results indicate that the
variables that significantly contribute to psoriasis disability are years of education, impact on social
life and body image. Body image-related cognitive fusion is a significant mediator in the relationship
between disease severity and acceptance, and psoriasis disability.
The main findings and strengths of this study are important on three different levels: (1) providing
psoriasis patients with information appropriate to their educational level in order to reduce distorted
perceptions of disease severity that may compromise their quality of life and adaptation to the
disease, (2) intervening in the ability to accept this specific long-term chronic health condition, and (3)
addressing issues associated with a negatively disproportionate body image in relation to the extent
and characteristics of the physical lesions.
The limitations of this study are related to the reduced number of samples used in this initial
exploratory study and the nature of the instruments, which are all self-reporting. In the future, studies
with a larger sample and a longitudinal design will be able to confirm and strengthen the results
obtained, contributing to a better understanding of the psoriasis disease experience and enabling a
multidisciplinary approach within integrated psoriasis treatment.
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